<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25498" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Myxedema</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Elshimy</surname>
            <given-names>Ghada</given-names>
          </name>
          <aff>University of Arizona</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chippa</surname>
            <given-names>Venu</given-names>
          </name>
          <aff>Indiana university</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Correa</surname>
            <given-names>Ricardo</given-names>
          </name>
          <aff>University of Arizona</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ghada Elshimy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Venu Chippa declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ricardo Correa declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25498.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Myxedema coma is a rare fatal condition resulting from long-standing hypothyroidism with loss of the adaptive mechanism to maintain homeostasis. Hypothyroidism due to any cause, including autoimmune disease, iodine deficiency, congenital abnormalities, or medications like lithium and amiodarone, can precipitate myxedema coma if left untreated. Even with early diagnosis and treatment of myxedema coma, the mortality rate is variable, with some reports as high as 60% and others as low as 20 to 25% in the presence of advanced intensive support care. Early recognition, a thorough history, physical exam, and early treatment are paramount in managing myxedema coma. This activity reviews the cause, pathophysiology, and presentation of myxedema and highlights the role of the interprofessional team in management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the history and physical exam of a patient with myxedema coma.</p></list-item><list-item><p>Identify the etiology of myxedema coma.</p></list-item><list-item><p>Outline the management options available for myxedema coma.</p></list-item><list-item><p>Review the importance of an interprofessional team for improving outcomes of myxedema coma.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25498&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25498">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25498.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Myxedema coma is a rare and extreme&#x000a0;complication&#x000a0;of hypothyroidism with multiple organ abnormalities&#x000a0;associated with altered sensorium, it can be fatal.&#x000a0;Hypothyroid patients exhibit multiple physiologic alterations to compensate for the deficiency of thyroid hormone. Factors like infection can overwhelm these homeostatic mechanisms and can lead to myxedema coma. Myxedema coma can be an initial presentation of any form of hypothyroidism, irrespective of the cause.<xref ref-type="bibr" rid="article-25498.r1">[1]</xref>&#x000a0;Even with early diagnosis and treatment of myxedema coma, the mortality rate is variable, with some reports as high as 60% and others as low as 20 to 25%&#x000a0;even with&#x000a0;intensive care.</p>
        <p>Myxedema is commonly used often in the context of hypothyroidism and myxedema coma, it also means edema of the skin and soft tissue in hypothyroidism.<xref ref-type="bibr" rid="article-25498.r2">[2]</xref>&#x000a0;Myxedema coma is a misnomer. Neither the patients have classic nonpitting edema, nor are they in a coma. The most salient feature of myxedema coma is deteriorating mentation.&#x000a0;</p>
        <p>A high index of suspicion, early recognition, admission to&#x000a0;intensive care units, and treatment with intravenous levothyroxine and hydrocortisone are paramount in the management of myxedema coma.<xref ref-type="bibr" rid="article-25498.r3">[3]</xref> History of any thyroid dysfunction, thyroid medication, adherence with thyroid medication, thyroid surgery, and history of any drugs that may affect thyroid function require assessment in any patient suspected myxedema coma.<xref ref-type="bibr" rid="article-25498.r4">[4]</xref></p>
      </sec>
      <sec id="article-25498.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Disrupted homeostatic mechanisms in hypothyroid patients lead to myxedema coma. There are many Precipitating factors. The most important are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Infections: urinary tract infection, pneumonia, viral infections, influenza, etc.</p>
          </list-item>
          <list-item>
            <p>Burns, carbon&#x000a0;dioxide retention, and trauma</p>
          </list-item>
          <list-item>
            <p>Hypothermia and hypoglycemia&#x000a0;<xref ref-type="bibr" rid="article-25498.r2">[2]</xref></p>
          </list-item>
          <list-item>
            <p>Hypoxemia and cerebrovascular accidents<xref ref-type="bibr" rid="article-25498.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Drugs: amiodarone<xref ref-type="bibr" rid="article-25498.r6">[6]</xref>, lithium<xref ref-type="bibr" rid="article-25498.r7">[7]</xref>, sedatives, tranquilizers, anesthetics<xref ref-type="bibr" rid="article-25498.r8">[8]</xref>, opioids, phenytoin, rifampin, diuretics, beta-blockers (given the slow drug metabolism in patients with hypothyroidism, these patients have a risk of an overdose of anesthetics and tranquilizers)</p>
          </list-item>
          <list-item>
            <p>New case reports with anti-TNF therapy causing myxedema have documentation in the literature.<xref ref-type="bibr" rid="article-25498.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Congestive heart failure&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Gastrointestinal bleeding</p>
          </list-item>
          <list-item>
            <p>Surgery (given the effect on&#x000a0;pituitary-thyroid axis with decrease thyroid hormones secretion after surgery in response to stress)<xref ref-type="bibr" rid="article-25498.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>A case report in 2019 showed that diabetic ketoacidosis precipitated myxedema coma in a patient after total thyroidectomy.<xref ref-type="bibr" rid="article-25498.r11">[11]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25498.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The exact incidence and prevalence of myxedema coma are not known, but some authors estimate an incidence of approximately 0.22 per 1000000 per year in the western world; however, there is no sufficient epidemiological data from other countries.<xref ref-type="bibr" rid="article-25498.r4">[4]</xref>&#x000a0;Myxedema coma is more common in females (80% of cases), as hypothyroidism is more common in women (four-fold more than men).<xref ref-type="bibr" rid="article-25498.r12">[12]</xref>&#x000a0;The population aged more than 60 years are more liable to have myxedema coma.<xref ref-type="bibr" rid="article-25498.r13">[13]</xref> Since the patients are usually hypothermic, myxedema coma is more common in the winter (90% of cases).<xref ref-type="bibr" rid="article-25498.r14">[14]</xref>&#x000a0;This fact is explained by decreased heat production with age and hypothyroidism and decreased thermoregulation with age.<xref ref-type="bibr" rid="article-25498.r15">[15]</xref></p>
      </sec>
      <sec id="article-25498.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The thyroid gland begins development during the fourth gestational week as an endodermal thickening of the floor of the primitive pharynx. Its final resting place is located in the anterior inferior visceral compartment of the neck and lies deep to the omohyoid, sternohyoid, and sternothyroid muscles. It is encased in the pretracheal fascia and accompanied by the pharynx, trachea, esophagus, and recurrent laryngeal nerve.<xref ref-type="bibr" rid="article-25498.r16">[16]</xref>&#x000a0;The thyroid has two lobes linked by an isthmus. It sometimes has a pyramidal lobe (40% of the population) that extends upward from the isthmus and is responsible for the production of two major hormones: thyroxine (T4), triiodothyronine (T3).<xref ref-type="bibr" rid="article-25498.r17">[17]</xref> These hormones are responsible for regulating whole-body metabolism, which can decrease by as much as 40 to 50 percent in the complete absence of these hormones and increase by as much as 60 to 100 percent with full secretion.</p>
        <p>The metabolically active hormones the thyroid secretes are T4 and T3 (around 93% T4 and 7% T3). T3 is four times more potent than T4, and the vast majority of T4 converts to T3 in the tissues. The half-life of T4 is seven days, while T3 has a much shorter half-life. Multiple proteins bind to T3 and T4. These proteins include thyroxine-binding globulin, transthyretin (TTR), and albumin. Production of the thyroid hormones by follicles lined by cuboidal epithelial cells occurs inside the thyroid gland. These follicles secrete colloid, which is composed of thyroglobulin and contains the thyroid hormones T3 and T4. At least 50 milligrams of iodine per year or 1 milligram per week are necessary for adequate hormone production.<xref ref-type="bibr" rid="article-25498.r18">[18]</xref></p>
        <p>Iodine is concentrated within the thyroid cell by a sodium-iodide symporter that pumps one iodide molecule and two sodium ions. The serum TSH level highly influences the activity of this symporter. A peroxidase enzyme then oxidizes iodide ions to iodine.<xref ref-type="bibr" rid="article-25498.r19">[19]</xref> Then organification occurs by binding iodine to the amino acid tyrosine located within the thyroglobulin molecule. Thyroglobulin is stored in the thyroid gland and contains approximately 30 molecules of T4 and a few molecules of T3. In the complete absence of the production of thyroid hormone, the thyroid contains enough reserve to last about 2 to 3 months.</p>
        <p>Thyroid hormone influences virtually all cells in the body by activating or repressing a variety of genes after binding to thyroid hormone receptors. Ninety percent of the intracellular thyroid hormone that binds to and influences cellular function is T3, which has been converted from T4 by the removal of an iodide ion. The thyroid hormone receptors associated with the DNA within the target genes are bound to retinoid X receptors at specific thyroid hormone response elements. Once bound, the transcription process begins, and hundreds of new intracellular proteins, mostly enzymes, are formed. One particular gene of importance is the gene that regulates the expression of calcium ATPase, which is especially important in maintaining efficient cardiac output.<xref ref-type="bibr" rid="article-25498.r20">[20]</xref>&#x000a0;Thyroid hormones do have some non-genomic effects on cells, which include the regulation of ion channels and oxidative phosphorylation. These effects are possibly under the mediation of the thyroid hormone-binding of the plasma membrane, cytoplasm, and cellular organelles. Other effects of thyroid hormone include increased Na-K-ATPase activity, increased carbohydrate metabolism, increased free fatty acids (decreased cholesterol, phospholipids, and triglycerides), increased vitamin requirements as a consequence of increased enzymes that use vitamins as cofactors, and overall increased metabolism. In light of thyroid hormone being responsible for a vast majority of bodily functions at the genetic and cellular level, it is easy to see how the extreme absence of this hormone, as seen in myxedema coma, is associated with a high mortality rate and has a broad spectrum of presenting symptoms.<xref ref-type="bibr" rid="article-25498.r21">[21]</xref></p>
        <p>Myxedema coma is a potentially fatal complication, and prompt diagnosis is an important factor in reducing mortality.<xref ref-type="bibr" rid="article-25498.r5">[5]</xref>&#x000a0;Identifying a precipitating cause is imperative. It is worth noting that a patient usually presents with hypothermia and is not febrile.<xref ref-type="bibr" rid="article-25498.r22">[22]</xref> However, an investigation for an infectious cause is warranted, particularly if the patient is minimally hypothermic as it may be masking the underlying infection.<xref ref-type="bibr" rid="article-25498.r15">[15]</xref> Particular drugs such as lithium and amiodarone have multiple case reports associating their use and precipitation of myxedema coma given their mechanism of action on the inhibition of thyroid hormone release.<xref ref-type="bibr" rid="article-25498.r23">[23]</xref> Lithium also inhibits cAMP production in response to TSH.&#x000a0;Patients on lithium also have been shown to have an exaggerated TSH response to TRH.<xref ref-type="bibr" rid="article-25498.r24">[24]</xref>&#x000a0;Amiodarone inhibits thyroid hormone entry into peripheral tissues, inhibits 5&#x02019;-deiodinase, converts T4 to T3, and releases excess iodine.<xref ref-type="bibr" rid="article-25498.r25">[25]</xref> Other precipitating factors such as hypoglycemia, hypoxemia, and hypercapnia may also be secondary to myxedema coma itself.</p>
        <p>A brief description of organ system-specific pathologic manifestations is described below.</p>
        <p>
<bold>Cardiac&#x000a0;Manifestations</bold>
</p>
        <p>Diastolic hypertension is one of the cardiovascular compensatory mechanisms in hypothyroidism. Hypothermia and decreased respiratory drive cause peripheral vasoconstriction, resulting in loss of protective mechanism and development of hypotension. Common cardiovascular symptoms include hypotension, shock, arrhythmia, and heart block. Myxedema causes decreased myocardial contractility and reduced cardiac output, which leads to hypotension.<xref ref-type="bibr" rid="article-25498.r26">[26]</xref> Bradycardia, flattened T waves, low voltage, bundle branch blocks, and complete heart blocks are common EKG findings.<xref ref-type="bibr" rid="article-25498.r27">[27]</xref>&#x000a0;Low voltage on EKG can be representative of pericardial effusion due to the accumulation of fluid rich in mucopolysaccharides and merits investigation.<xref ref-type="bibr" rid="article-25498.r28">[28]</xref> Fatal arrhythmias are important to recognize in Myxedema and chronic hypothyroidism<xref ref-type="bibr" rid="article-25498.r5">[5]</xref>. There have been cases showing QT interval prolongations leading to &#x0201c;torsades de pointes,&#x0201d; which resolves with treatment of myxedema. Myocardial infarction is important to rule out as aggressive T4 replacement may increase the risk of myocardial infarction.<xref ref-type="bibr" rid="article-25498.r29">[29]</xref></p>
        <p>
<bold>Neurological&#x000a0;Manifestations</bold>
</p>
        <p>Myxedema coma course is commonly a slow progression to coma. Typically patients do not present with coma, especially in the early phase, but they present with lethargy. Hence the name of myxedema coma itself can be misleading. Other findings may include depression, disorientation, decrease deep tendon reflexes, psychosis, slow mentation, paranoia, and poor recall.<xref ref-type="bibr" rid="article-25498.r30">[30]</xref>&#x000a0;One case describes a rare presentation of a patient with status epilepticus.<xref ref-type="bibr" rid="article-25498.r31">[31]</xref>&#x000a0;Lumbar punctures, which are usually done during the investigation of underlying causes to rule out infections, can show increased pressure and high protein count in these situations, attributable to increased meningeal permeability and cerebral blood flow and a decrease in metabolism.<xref ref-type="bibr" rid="article-25498.r32">[32]</xref></p>
        <p>
<bold>Respiratory&#x000a0;Manifestations</bold>
</p>
        <p>Hypoventilation in myxedema coma is due to impaired hypoxic and hypercapnic ventilatory response and the associated diaphragmatic muscle weakness.<xref ref-type="bibr" rid="article-25498.r33">[33]</xref>&#x000a0;The primary cause of coma in myxedema appears to be due to respiratory depression due to decreased response to hypercapnia.<xref ref-type="bibr" rid="article-25498.r27">[27]</xref>&#x000a0;Also, swelling of the tongue and vocal cords leads to obstructive sleep apnea contributing to respiratory failure. Another issue that can contribute is a reduction in tidal volume due to pleural effusion or ascites.<xref ref-type="bibr" rid="article-25498.r34">[34]</xref></p>
        <p>
<bold>Gastrointestinal&#x000a0;Manifestations</bold>
</p>
        <p>Myxedema coma commonly causes abdominal pain, nausea, vomiting, ileus, anorexia, constipation, and ascites.<xref ref-type="bibr" rid="article-25498.r35">[35]</xref>&#x000a0;Ileus is of particular importance as it can lead to megacolon. Ascites have also been seen in cases of myxedema but are not common. There are reports of only a few cases in the literature. These gastric complications may also cause issues with the absorption of oral medications. Gastrointestinal bleeding can occur as myxedema has a higher risk of bleeds due to coagulopathy-related complications.<xref ref-type="bibr" rid="article-25498.r36">[36]</xref><xref ref-type="bibr" rid="article-25498.r37">[37]</xref></p>
        <p>
<bold>Renal and Electrolyte Manifestations</bold>
</p>
        <p>Typical findings in myxedema coma are hyponatremia and decreased glomerular filtration rate.<xref ref-type="bibr" rid="article-25498.r38">[38]</xref>&#x000a0;Hyponatremia occurs mainly due to decreased water transport to the distal nephron.<xref ref-type="bibr" rid="article-25498.r39">[39]</xref> Other causes can be an increase in antidiuretic hormone (ADH).<xref ref-type="bibr" rid="article-25498.r40">[40]</xref> Hyponatremia is also a key factor in the patient&#x02019;s altered mental status and development of a coma.<xref ref-type="bibr" rid="article-25498.r41">[41]</xref> Urinary sodium excretion is increased or normal. Urinary osmolality elevates relative to plasma osmolality.<xref ref-type="bibr" rid="article-25498.r42">[42]</xref> Patients may also have bladder atony causing urinary retention.</p>
        <p>
<bold>Hematologic Manifestations</bold>
</p>
        <p>Patients with myxedema coma have an increased risk of bleeding due to an acquired von Willebrand syndrome type 1 and a decrease in factors V, VII, VIII, IX, and X.<xref ref-type="bibr" rid="article-25498.r43">[43]</xref> This is unlike those with only mild hypothyroidism, which causes a hypercoagulable state. Cases have shown that acquired von Willebrand syndrome is reversible with T4 therapy.<xref ref-type="bibr" rid="article-25498.r44">[44]</xref></p>
      </sec>
      <sec id="article-25498.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients most commonly present for emergency services with altered mental status and hypothermia, below 35.5&#x000b0;C (95.9&#x000b0; F). The lower the body temperature, the worst is the prognosis.<xref ref-type="bibr" rid="article-25498.r45">[45]</xref> The absence of mild diastolic hypertension in severely hypothyroid patients is a warning sign of impending myxedema coma.<xref ref-type="bibr" rid="article-25498.r46">[46]</xref>&#x000a0;Due to the presence of altered mental status, a definitive history may be difficult to obtain. Important historical features include any thyroid dysfunction, the dosage of thyroid medication, adherence with thyroid medication, thyroid surgery, and history of any drugs that may affect thyroid function. A quick and detailed physical examination is a must in the initial assessment of myxedema coma. A physical exam can help confirm the suspicion of thyroid history by findings of no palpable thyroid tissue, goiter, sparse hair, non-pitting edema, a surgical scar on the neck, or dry skin. Some elderly patients&#x000a0;have atypical presentations, such as decreased mobility.<xref ref-type="bibr" rid="article-25498.r47">[47]</xref></p>
        <p>The salient features in the examination are as follows.</p>
        <list list-type="bullet">
          <list-item>
            <p>Altered mentation - can be very subtle, like depressed affect, apathy, decreased intellectual capacity, confusion, short attention span, and disorientation. Rarely psychosis and coma. All patients with decreased alertness need to be screened for depression.</p>
          </list-item>
          <list-item>
            <p>Hypoventilation and sleep apnea</p>
          </list-item>
          <list-item>
            <p>Hypothermia - hypoglycemia and cold weather may present as severe&#x000a0;hypothermia. Not every patient is hypothermic, and some patients may be normothermic.</p>
          </list-item>
          <list-item>
            <p>Dry, cool, and doughy skin (nonpitting edema, puffiness)</p>
          </list-item>
          <list-item>
            <p>Alopecia</p>
          </list-item>
          <list-item>
            <p>Decreased mobility</p>
          </list-item>
          <list-item>
            <p>Delayed reflex relaxation</p>
          </list-item>
          <list-item>
            <p>Diastolic hypertension followed by hypotension</p>
          </list-item>
          <list-item>
            <p>Bradycardia</p>
          </list-item>
          <list-item>
            <p>Bladder dystonia and distention</p>
          </list-item>
          <list-item>
            <p>Abdominal distention, paralytic ileus causing megacolon</p>
          </list-item>
          <list-item>
            <p>Fecal impaction (always perform rectal examination)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25498.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A high index of clinician suspicion for myxedema coma is important. As discussed above, patients who present will most likely be women in the winter months with a history of thyroid disorders and a precipitating illness. The two most common findings will be altered mental status and hypothermia, along with common findings of hypothyroidism. Other common signs include hyponatremia, hypotension, bradycardia, and hypoventilation. Laboratory results in primary hypothyroidism will show severely low or undetected low serum total T4, free T4, free T3, and elevated TSH. The underlying etiology for most patients is a primary thyroid failure, but secondary, tertiary, and sick euthyroid should be in the differential diagnosis.<xref ref-type="bibr" rid="article-25498.r48">[48]</xref> In euthyroid sick syndrome, TSH will not be as elevated as expected. In a small percentage of patients, central hypothyroidism should be a consideration. In these patients, TSH may be inappropriately low. The method to distinguish central versus primary hypothyroidism is that the associated pituitary hormones will decrease as well.<xref ref-type="bibr" rid="article-25498.r22">[22]</xref></p>
        <p>
<bold>Laboratory Abnormalities in Myxedema Coma</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Anemia (either normocytic or macrocytic anemia) and leukopenia<xref ref-type="bibr" rid="article-25498.r49">[49]</xref></p>
          </list-item>
          <list-item>
            <p>Elevated creatinine phosphokinase can lead to misdiagnosis of myocardial infarction<xref ref-type="bibr" rid="article-25498.r50">[50]</xref></p>
          </list-item>
          <list-item>
            <p>Elevated transaminases</p>
          </list-item>
          <list-item>
            <p>Hyperlipidemia due to inhibition of lipoprotein lipase enzyme</p>
          </list-item>
          <list-item>
            <p>Hypoglycemia due to downregulation of metabolism)</p>
          </list-item>
          <list-item>
            <p>Hyponatremia with low serum osmolarity and elevated creatinine (increase ADH with a decreased ability of kidneys to excrete water)<xref ref-type="bibr" rid="article-25498.r39">[39]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Other Required Investigations</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Septic workup to rule out infection, including cultures and chest X-ray, etc.<xref ref-type="bibr" rid="article-25498.r51">[51]</xref></p>
          </list-item>
          <list-item>
            <p>EKG can show bradycardia with non-specific changes, decrease voltage, variable block, or prolong QT interval</p>
          </list-item>
          <list-item>
            <p>Arterial blood gases can show hypoxia, hypercapnia, and respiratory acidosis.</p>
          </list-item>
          <list-item>
            <p>If cardiomegaly is present on imaging studies, further investigations to rule out pericardial effusion are necessary (echocardiogram)</p>
          </list-item>
          <list-item>
            <p>Neurological investigations like lumbar puncture usually show elevated protein with non-specific EEG changes.<xref ref-type="bibr" rid="article-25498.r52">[52]</xref></p>
          </list-item>
        </list>
        <p>A retrospective study in 2014 proposed a diagnostic score on 14 patients with myxedema coma and seven patients without myxedema coma, where a score greater than or equal to 60 in the proposed scoring system is potentially diagnostic. Lower scores between 45 and 59 demonstrate a risk of developing myxedema coma. The scoring system consisted of&#x000a0;alterations of thermoregulatory, central nervous, cardiovascular, gastrointestinal, and metabolic systems and the presence or absence of a precipitating event.<xref ref-type="bibr" rid="article-25498.r53">[53]</xref></p>
      </sec>
      <sec id="article-25498.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Since myxedema coma has a high mortality rate of up 60%, all patients require admission to the intensive care unit.<xref ref-type="bibr" rid="article-25498.r54">[54]</xref> There is documented higher mortality in elderly females, cardiac arrhythmias, persistent hypothermia, reduced consciousness, and sepsis.<xref ref-type="bibr" rid="article-25498.r55">[55]</xref>&#x000a0;Treating myxedema coma is a multisystem challenge. The identification of the precipitating factor is essential. Respiratory and airway management is a critical component in the management of the patient. Frequent monitoring of the arterial blood gas should be performed to monitor the hypercapnia and hypoxemia. Most will require mechanical ventilation as the altered mental status does leave patients more prone to aspiration, and airway obstruction could occur due to the myxedema of the larynx. Patients should not stop receiving ventilator support until the resolution of both hypercapnia and hypoxemia, as well as the patient regaining consciousness. Also, assessment for any pneumonia with imaging is needed to ensure the treatment of any precipitating factors.<xref ref-type="bibr" rid="article-25498.r56">[56]</xref> One should also initiate fluid resuscitation while monitoring sodium and slow rewarming to avoid further hypotension. Workup for infection etiology, including lumbar puncture, blood, urine cultures, empiric antibiotics in addition to appropriate imaging and interventions as a working diagnosis necessitates.<xref ref-type="bibr" rid="article-25498.r57">[57]</xref></p>
        <p>Hypothermia should be managed with warming blankets and increasing the temperature in the room. Care in warming the patient is advised as this will cause peripheral vasodilation and may lead to hypotension and shock. As the patient receives treatment with thyroid replacement, the hypothermia will slowly resolve. Hypotension requires careful management due to multiple issues commonly present concurrently, such as hyponatremia, hypoglycemia, and hypothermia. As stated above, rapid rewarming of the patient will increase vasodilation, worsening hypotension. This action necessitates the use of fluids to maintain hemodynamic stability. If hypotension is refractory to IV fluid resuscitation, then vasopressors should be initiated until Levothyroxine has time to act. If hypoglycemia is present, 5 to 10% dextrose with half normal saline should be administered carefully. The dilemma occurs if the patient presents with hyponatremia as well. Hypotonic fluids should be avoided. Low sodium can precipitate altered mental status, and correcting the deficiency is vital. There is a careful balance between fluid restriction and the need for fluids. A central venous line is also a recommendation.<xref ref-type="bibr" rid="article-25498.r39">[39]</xref> If hyponatremia is severe (below 120 mmol/L), careful administration of 3% sodium chloride along with intravenous bolus furosemide to allow for proper diuresis. A 4 to 6 mmol/L increase in serum sodium concentration is shown to correct many neurological symptoms.&#x000a0;Slow correction is vital as overcorrection increases the risk for osmotic demyelination syndrome. Current research suggests that the correct rate should not increase more than 6 to 8 mmol/L in 24 hours. Once serum sodium levels rise above mmol/L, fluid restrictions should be sufficient in correcting serum sodium.<xref ref-type="bibr" rid="article-25498.r58">[58]</xref></p>
        <p>Prompt initiation of thyroid hormone therapy is of paramount importance when myxedema coma is highly suspected, even before having thyroid hormone results back (even though results usually come back quickly in most clinical institutions).<xref ref-type="bibr" rid="article-25498.r59">[59]</xref> A delay could increase the mortality and morbidity of the patient.<xref ref-type="bibr" rid="article-25498.r60">[60]</xref>&#x000a0;Hydrocortisone is recommended to be administered prior to thyroid hormone therapy, especially if the patient is hypotensive to avoid adrenal crises; suggestions are that levothyroxine will increase cortisol metabolism, and hypothyroidism may mask an underlying adrenal insufficiency.<xref ref-type="bibr" rid="article-25498.r61">[61]</xref>&#x000a0;A recommended course of therapy, if possible, is to draw blood for random cortisol, TSH, FT4, FT3 and administer hydrocortisone starting with a 100 mg IV initiating dose (total 200 to 400 mg daily) which can be stopped or weaned down based on cortisol when blood levels are back, and hypotension resolves.<xref ref-type="bibr" rid="article-25498.r62">[62]</xref>&#x000a0;The administration of IV Levothyroxine should follow. Repeat TSH, FT4, and FT3 are the basis for dose adjustment.<xref ref-type="bibr" rid="article-25498.r60">[60]</xref>&#x000a0;</p>
        <p>According to the most recent American Thyroid Association (ATA) guidelines, the recommended initial dose is 200 to 400 mcg IV once (lower dose for elderly, or underlying cardiac disease or arrhythmia with some reports up to 500 mcg). Subsequently, dosing is 1.6 mcg/kg/day, reduced to 75% when given IV as a preferred route, for patients may not be able to tolerate PO, and the absorption could be impaired secondary to intestinal impaired motility and edema. TSH, FT4, FT3 should be measured at baseline and then every 24 to 48 hours until the patient's mental status starts to improve.<xref ref-type="bibr" rid="article-25498.r59">[59]</xref> There is still a controversy on what is the optimal dose, for a higher dose may cause harm, particularly in elderly patients or in patients with underlying cardiac disease and arrhythmia.<xref ref-type="bibr" rid="article-25498.r3">[3]</xref> Consider adding LT3 at a loading dose of 5 to 20 micrograms followed by 2.5 to 10 micrograms IV every 8 hours if no response within 24 hours (weak recommendation, low quality of evidence). Caution should be exercised again with patients with underlying heart disease or a history of cardiac arrhythmia since a case series showed increased adverse outcomes with higher doses of LT3 therapy.<xref ref-type="bibr" rid="article-25498.r60">[60]</xref>&#x000a0;Another controversy is whether liothyronine (LT3) is appropriate for patients whose mental status does not improve in 24 to 48 hours after administration of levothyroxine or with undetectable FT3 levels. It is well known that the conversion of FT4 to FT3 at the cellular level will be impaired in severely ill patients and those on steroids.<xref ref-type="bibr" rid="article-25498.r60">[60]</xref> However, this impaired conversion may sometimes be a protective mechanism to slow down metabolism in patients who are severely ill to preserve organ function. Whether this phenomenon can be extrapolated to patients with myxedema coma is still controversial.<xref ref-type="bibr" rid="article-25498.r63">[63]</xref> It remains very important, however, to properly dose LT3 for high levels correlate with increased mortality.<xref ref-type="bibr" rid="article-25498.r54">[54]</xref></p>
        <p>One case report in 2017 split dose of levothyroxine to 200 mcg LT4 every 8 h in five consecutive doses (total dose of 1 mg) resulted in significant restoration of depleted thyroid status and clinical improvement within 48 hours after treatment initiation.<xref ref-type="bibr" rid="article-25498.r64">[64]</xref>&#x000a0;Another case reports in 2019 treated the patient with a combination of levothyroxine 200 mcg with liothyronine 50 mcg for five days, with a successful improvement of the patient's condition, so some reports recommended starting with 200 to 300 mcg levothyroxine with 10 to 25 mcg liothyronine as an alternative initial treatment.<xref ref-type="bibr" rid="article-25498.r65">[65]</xref> While optimal levels for serum TSH and thyroid hormones are not well defined in these circumstances, failure of TSH to trend down or for thyroid hormone levels to improve could be considered indications to increase levothyroxine therapy and/or add LT3 therapy, whereas high serum triiodothyronine (FT3) is an indication to decrease therapy given safety concerns. An in vitro study on rats by Mooradian et al. concluded that aging is associated with reduced responsiveness to T3-stimulated up-regulation of beta-adrenergic receptor number in synaptosomal membranes, and it did not improve with higher doses of LT3.<xref ref-type="bibr" rid="article-25498.r63">[63]</xref></p>
        <p>The severity of myxedema coma should not rely solely on higher levels of TSH, for it does not always correlate either secondary to suppression of the hypothalamic-pituitary axis in critically ill patients, a slower response in the elderly, or secondary hypothyroidism from pituitary causes. The expectation for serum FT4 to show normalization in 4 days after starting therapy.<xref ref-type="bibr" rid="article-25498.r66">[66]</xref></p>
      </sec>
      <sec id="article-25498.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnosis has its basis on signs and symptoms; for example, the differential diagnosis of altered mental status<xref ref-type="bibr" rid="article-25498.r67">[67]</xref>&#x000a0;or coma would include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Sepsis</p>
          </list-item>
          <list-item>
            <p>Shock</p>
          </list-item>
          <list-item>
            <p>Stroke</p>
          </list-item>
          <list-item>
            <p>Drug overdose</p>
          </list-item>
          <list-item>
            <p>Diabetic ketoacidosis</p>
          </list-item>
          <list-item>
            <p>Seizure</p>
          </list-item>
          <list-item>
            <p>Hypothermia<xref ref-type="bibr" rid="article-25498.r67">[67]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25498.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis for myxedema coma is difficult to establish due to the small number of cases reported. The mortality rate is variable, with some reports as high as 60% and others as low as 20 to 25% in the presence of advanced intensive support care.<xref ref-type="bibr" rid="article-25498.r68">[68]</xref>&#x000a0;Poor prognosis is likely related to&#x000a0;advanced age, bradycardia, and persistent hypothermia.<xref ref-type="bibr" rid="article-25498.r54">[54]</xref></p>
      </sec>
      <sec id="article-25498.s11" sec-type="Complications">
        <title>Complications</title>
        <p>If left untreated, myxedema coma is fatal.<xref ref-type="bibr" rid="article-25498.r5">[5]</xref>&#x000a0;Complications of myxedema include coma, respiratory failure, myocardial ischemia, sepsis, and gastrointestinal hemorrhage.<xref ref-type="bibr" rid="article-25498.r22">[22]</xref></p>
      </sec>
      <sec id="article-25498.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>An endocrinology consult is warranted once the diagnosis of myxedema coma is suspected.</p>
        <p>If the patient is experiencing arrhythmia, respiratory distress, or multiorgan failure, an interprofessional team should be on board, including the cardiology team, pulmonary team, intensivists, and endocrinology team.</p>
      </sec>
      <sec id="article-25498.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The patients should receive education about the importance of compliance with medications and monitoring thyroid function tests after starting certain medications like amiodarone, lithium, anti-TNF, etc.</p>
      </sec>
      <sec id="article-25498.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Myxedema coma is often a fatal complication, and prompt diagnosis is an important factor in reducing mortality.<xref ref-type="bibr" rid="article-25498.r5">[5]</xref> This disorder is best managed by an interprofessional team to enable prompt diagnosis and management. Identifying a precipitating cause is imperative.<xref ref-type="bibr" rid="article-25498.r22">[22]</xref>&#x000a0;Effective treatment calls for a team-based and patient-centered approach. An endocrinology consult is necessary on clinical suspicion.<xref ref-type="bibr" rid="article-25498.r15">[15]</xref></p>
        <p>These patients need care in an ICU setting. Besides the clinicians, ICU nurses play a critical role in management. Hypothermia requires management, and patients need IV hydration. The airways must remain patent, and any respiratory distress requires mechanical ventilation. Continuous cardiac monitoring is vital, as well as hemodynamics. Nurses should communicate any deviation from normal parameters to the team immediately. Also, patients required IV thyroid hormone replacement and corticosteroids. Other specialists involved in the care include pharmacists, endocrinologists, and pulmonologists. Since most patients are not able to eat, a dietary consult for parenteral or enteral nutrition is needed. Pharmacists specializing in nutritional management must be involved and report to the team as challenges arise.</p>
        <p>The medications used in the management of myxedema coma require the intervention of a pharmacist to ensure proper dosing, drug-drug interaction checking, and overall medication reconciliation; the pharmacist should communicate any concerns to the rest of the interprofessional team.</p>
        <p>Prompt recognition of the condition by checking thyroid function tests and rapid intervention&#x000a0;is essential for&#x000a0;survival.&#x000a0;</p>
        <p>After discharge, clinicians, nurses, and pharmacists should educate patients about the need to take the thyroid hormone and undergo regular testing. Patients should be advised to report any new medication that may interfere with thyroid function or metabolism.</p>
        <p>In summary, myxedema coma requires an interprofessional team approach, including physicians, specialists, specialty-trained nurses, and pharmacists, all collaborating across disciplines to achieve optimal patient results. [Level 5]</p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>Myxedema is a serious disorder with high mortality. Most patients die from GI bleeding, sepsis, or respiratory failure despite optimal treatment. Poor prognostic factors include advanced age, persistent hypothermia, and altered mental status.</p>
      </sec>
      <sec id="article-25498.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25498&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25498">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/myxedema/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25498">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25498/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25498">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25498.s16">
        <title>References</title>
        <ref id="article-25498.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jordan</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Myxedema coma. Pathophysiology, therapy, and factors affecting prognosis.</article-title>
            <source>Med Clin North Am</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>79</volume>
            <issue>1</issue>
            <fpage>185</fpage>
            <page-range>185-94</page-range>
            <pub-id pub-id-type="pmid">7808091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wall</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Myxedema coma: diagnosis and treatment.</article-title>
            <source>Am Fam Physician</source>
            <year>2000</year>
            <month>Dec</month>
            <day>01</day>
            <volume>62</volume>
            <issue>11</issue>
            <fpage>2485</fpage>
            <page-range>2485-90</page-range>
            <pub-id pub-id-type="pmid">11130234</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamamoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fukuyama</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fujiyoshi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Factors associated with mortality of myxedema coma: report of eight cases and literature survey.</article-title>
            <source>Thyroid</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>12</issue>
            <fpage>1167</fpage>
            <page-range>1167-74</page-range>
            <pub-id pub-id-type="pmid">10646654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodr&#x000ed;guez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fluiters</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-M&#x000e9;ndez</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Luna</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>P&#x000e1;ramo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Mayor</surname>
                <given-names>RV</given-names>
              </name>
            </person-group>
            <article-title>Factors associated with mortality of patients with myxoedema coma: prospective study in 11 cases treated in a single institution.</article-title>
            <source>J Endocrinol</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>180</volume>
            <issue>2</issue>
            <fpage>347</fpage>
            <page-range>347-50</page-range>
            <pub-id pub-id-type="pmid">14765987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mathew</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Misgar</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mukhopadhyay</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Roychowdhury</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pandit</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mukhopadhyay</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chowdhury</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Myxedema coma: a new look into an old crisis.</article-title>
            <source>J Thyroid Res</source>
            <year>2011</year>
            <volume>2011</volume>
            <fpage>493462</fpage>
            <pub-id pub-id-type="pmid">21941682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mazonson</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Cantley</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Dalldorf</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Utiger</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Myxedema coma during long-term amiodarone therapy.</article-title>
            <source>Am J Med</source>
            <year>1984</year>
            <month>Oct</month>
            <volume>77</volume>
            <issue>4</issue>
            <fpage>751</fpage>
            <page-range>751-4</page-range>
            <pub-id pub-id-type="pmid">6486153</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waldman</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Myxedema coma associated with lithium therapy.</article-title>
            <source>Am J Med</source>
            <year>1989</year>
            <month>Sep</month>
            <volume>87</volume>
            <issue>3</issue>
            <fpage>355</fpage>
            <page-range>355-6</page-range>
            <pub-id pub-id-type="pmid">2773973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bajwa</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Sehgal</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Anesthesia and thyroid surgery: The never ending challenges.</article-title>
            <source>Indian J Endocrinol Metab</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>228</fpage>
            <page-range>228-34</page-range>
            <pub-id pub-id-type="pmid">23776893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Myxoedema coma following commencement of anti-TNF therapy and tuberculosis prophylaxis in a patient with RA and latent tuberculosis infection.</article-title>
            <source>Postgrad Med J</source>
            <year>2019</year>
            <month>May</month>
            <volume>95</volume>
            <issue>1123</issue>
            <fpage>281</fpage>
            <pub-id pub-id-type="pmid">31085622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ilias</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tzanela</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mavrou</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Douka</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kopterides</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Armaganidis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Orfanos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kostopanagiotou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Macheras</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tsagarakis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dimopoulou</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Thyroid function changes and cytokine alterations following major surgery.</article-title>
            <source>Neuroimmunomodulation</source>
            <year>2007</year>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>243</fpage>
            <page-range>243-7</page-range>
            <pub-id pub-id-type="pmid">18073499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>EY</given-names>
              </name>
            </person-group>
            <article-title>Myxedema coma precipitated by diabetic ketoacidosis after total thyroidectomy: a case report.</article-title>
            <source>J Med Case Rep</source>
            <year>2019</year>
            <month>Mar</month>
            <day>04</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>50</fpage>
            <pub-id pub-id-type="pmid">30827279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roberts</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Ladenson</surname>
                <given-names>PW</given-names>
              </name>
            </person-group>
            <article-title>Hypothyroidism.</article-title>
            <source>Lancet</source>
            <year>2004</year>
            <month>Mar</month>
            <day>06</day>
            <volume>363</volume>
            <issue>9411</issue>
            <fpage>793</fpage>
            <page-range>793-803</page-range>
            <pub-id pub-id-type="pmid">15016491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davis</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>FB</given-names>
              </name>
            </person-group>
            <article-title>Hypothyroidism in the elderly.</article-title>
            <source>Compr Ther</source>
            <year>1984</year>
            <month>Apr</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>17</fpage>
            <page-range>17-23</page-range>
            <pub-id pub-id-type="pmid">6426851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsitouras</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Myxedema coma.</article-title>
            <source>Clin Geriatr Med</source>
            <year>1995</year>
            <month>May</month>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>251</fpage>
            <page-range>251-8</page-range>
            <pub-id pub-id-type="pmid">7606694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bailes</surname>
                <given-names>BK</given-names>
              </name>
            </person-group>
            <article-title>Hypothyroidism in elderly patients.</article-title>
            <source>AORN J</source>
            <year>1999</year>
            <month>May</month>
            <volume>69</volume>
            <issue>5</issue>
            <fpage>1026</fpage>
            <page-range>1026-30</page-range>
            <pub-id pub-id-type="pmid">10332556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r16">
          <label>16</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mnatsakanian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al Khalili</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <chapter-title>Anatomy, Head and Neck, Thyroid Muscles</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>24</day>
            <pub-id pub-id-type="pmid">31082107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gervasio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mujahed</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Biasio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alessi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound anatomy of the neck: The infrahyoid region.</article-title>
            <source>J Ultrasound</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>85</fpage>
            <page-range>85-9</page-range>
            <pub-id pub-id-type="pmid">23396844</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johansson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Andersson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>&#x000d6;rnros</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Carlsson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ingeson-Carlsson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dahlberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jansson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Parrillo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zoppoli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Barila</surname>
                <given-names>GO</given-names>
              </name>
              <name>
                <surname>Altschuler</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Padula</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lickert</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fagman</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Revising the embryonic origin of thyroid C cells in mice and humans.</article-title>
            <source>Development</source>
            <year>2015</year>
            <month>Oct</month>
            <day>15</day>
            <volume>142</volume>
            <issue>20</issue>
            <fpage>3519</fpage>
            <page-range>3519-28</page-range>
            <pub-id pub-id-type="pmid">26395490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pankow</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Michalak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McGee</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>Adult human thyroid weight.</article-title>
            <source>Health Phys</source>
            <year>1985</year>
            <month>Dec</month>
            <volume>49</volume>
            <issue>6</issue>
            <fpage>1097</fpage>
            <page-range>1097-103</page-range>
            <pub-id pub-id-type="pmid">4077513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r20">
          <label>20</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Rousset</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dupuy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Miot</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dumont</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <chapter-title>Chapter 2 Thyroid Hormone Synthesis And Secretion</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Feingold</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Anawalt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Blackman</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Boyce</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chrousos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Corpas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>de Herder</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Dhatariya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dungan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hofland</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kalra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaltsas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kapoor</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kopp</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Korbonits</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kovacs</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kuohung</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Laferr&#x000e8;re</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McGee</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>McLachlan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>New</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Purnell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sahay</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Stratakis</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Trence</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <source>Endotext [Internet]</source>
            <publisher-name>MDText.com, Inc.</publisher-name>
            <publisher-loc>South Dartmouth (MA)</publisher-loc>
            <year>2015</year>
            <month>9</month>
            <day>2</day>
            <pub-id pub-id-type="pmid">25905405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Herle</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Vassart</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dumont</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Control of thyroglobulin synthesis and secretion. (First of two parts).</article-title>
            <source>N Engl J Med</source>
            <year>1979</year>
            <month>Aug</month>
            <day>02</day>
            <volume>301</volume>
            <issue>5</issue>
            <fpage>239</fpage>
            <page-range>239-49</page-range>
            <pub-id pub-id-type="pmid">221813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murthy</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Rangappa</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jacob</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Janakiraman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Myxoedema coma in adults: Experience from a tertiary referral hospital intensive care unit.</article-title>
            <source>Indian J Anaesth</source>
            <year>2015</year>
            <month>May</month>
            <volume>59</volume>
            <issue>5</issue>
            <fpage>315</fpage>
            <page-range>315-7</page-range>
            <pub-id pub-id-type="pmid">26019358</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Padmanabhan</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Amiodarone and thyroid dysfunction.</article-title>
            <source>South Med J</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>103</volume>
            <issue>9</issue>
            <fpage>922</fpage>
            <page-range>922-30</page-range>
            <pub-id pub-id-type="pmid">20689491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santiago</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rashkin</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Lithium toxicity and myxedema coma in an elderly woman.</article-title>
            <source>J Emerg Med</source>
            <year>1990</year>
            <season>Jan-Feb</season>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-6</page-range>
            <pub-id pub-id-type="pmid">2191030</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hawatmeh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thawabi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abuarqoub</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shamoon</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Amiodarone induced myxedema coma: Two case reports and literature review.</article-title>
            <source>Heart Lung</source>
            <year>2018</year>
            <season>Jul-Aug</season>
            <volume>47</volume>
            <issue>4</issue>
            <fpage>429</fpage>
            <page-range>429-431</page-range>
            <pub-id pub-id-type="pmid">29793782</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacKerrow</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Osborn</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Eaton</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Economou</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Myxedema-associated cardiogenic shock treated with intravenous triiodothyronine.</article-title>
            <source>Ann Intern Med</source>
            <year>1992</year>
            <month>Dec</month>
            <day>15</day>
            <volume>117</volume>
            <issue>12</issue>
            <fpage>1014</fpage>
            <page-range>1014-5</page-range>
            <pub-id pub-id-type="pmid">1443970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chatzitomaris</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Scheeler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gotzmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>K&#x000f6;ditz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schildroth</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Knyhala</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Nicolas</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Heyer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>M&#x000fc;gge</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Dietrich</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Second degree AV block and severely impaired contractility in cardiac myxedema: a case report.</article-title>
            <source>Thyroid Res</source>
            <year>2015</year>
            <volume>8</volume>
            <fpage>6</fpage>
            <pub-id pub-id-type="pmid">26000037</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Majid-Moosa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schussler</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mora</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Myxedema coma with cardiac tamponade and severe cardiomyopathy.</article-title>
            <source>Proc (Bayl Univ Med Cent)</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>28</volume>
            <issue>4</issue>
            <fpage>509</fpage>
            <page-range>509-11</page-range>
            <pub-id pub-id-type="pmid">26424958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schenck</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Rizvi</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Severe primary hypothyroidism manifesting with torsades de pointes.</article-title>
            <source>Am J Med Sci</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>331</volume>
            <issue>3</issue>
            <fpage>154</fpage>
            <page-range>154-6</page-range>
            <pub-id pub-id-type="pmid">16538077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ueno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tsuboi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fujimaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eguchi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Machida</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hattori</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Miwa</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Acute psychosis as an initial manifestation of hypothyroidism: a case report.</article-title>
            <source>J Med Case Rep</source>
            <year>2015</year>
            <month>Nov</month>
            <day>17</day>
            <volume>9</volume>
            <fpage>264</fpage>
            <pub-id pub-id-type="pmid">26577152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fj&#x000f8;lner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>S&#x000f8;ndergaard</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kampmann</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Complete recovery after severe myxoedema coma complicated by status epilepticus.</article-title>
            <source>BMJ Case Rep</source>
            <year>2015</year>
            <month>Mar</month>
            <day>25</day>
            <volume>2015</volume>
            <pub-id pub-id-type="pmid">25809434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Constant</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>de Volder</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Ivanoiu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bol</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Labar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Seghers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cosnard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Melin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Daumerie</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography study.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>86</volume>
            <issue>8</issue>
            <fpage>3864</fpage>
            <page-range>3864-70</page-range>
            <pub-id pub-id-type="pmid">11502825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vargas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tibullo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Carifi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cucciniello</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Landi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Barbella</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Di Grezia</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Type 2 respiratory failure and falls in elderly adults: beware of the thyroid!</article-title>
            <source>J Am Geriatr Soc</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>62</volume>
            <issue>10</issue>
            <fpage>2026</fpage>
            <page-range>2026-7</page-range>
            <pub-id pub-id-type="pmid">25333562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ji</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Chae</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>BI</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>KY</given-names>
              </name>
            </person-group>
            <article-title>Myxedema ascites: case report and literature review.</article-title>
            <source>J Korean Med Sci</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>761</fpage>
            <page-range>761-4</page-range>
            <pub-id pub-id-type="pmid">16891828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khalid</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Asad-Ur-Rahman</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Abbass</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gordon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Abusaada</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Myxedema Ascites: A Rare Presentation of Uncontrolled Hypothyroidism.</article-title>
            <source>Cureus</source>
            <year>2016</year>
            <month>Dec</month>
            <day>05</day>
            <volume>8</volume>
            <issue>12</issue>
            <fpage>e912</fpage>
            <pub-id pub-id-type="pmid">28083456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Michiels</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Schroyens</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Berneman</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>van der Planken</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine.</article-title>
            <source>Clin Appl Thromb Hemost</source>
            <year>2001</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>113</fpage>
            <page-range>113-5</page-range>
            <pub-id pub-id-type="pmid">11292187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manfredi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>van Zaane</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gerdes</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Brandjes</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Squizzato</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hypothyroidism and acquired von Willebrand's syndrome: a systematic review.</article-title>
            <source>Haemophilia</source>
            <year>2008</year>
            <month>May</month>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>423</fpage>
            <page-range>423-33</page-range>
            <pub-id pub-id-type="pmid">18218015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iwasaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Oiso</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yamauchi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takatsuki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kondo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hasegawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tomita</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Osmoregulation of plasma vasopressin in myxedema.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1990</year>
            <month>Feb</month>
            <volume>70</volume>
            <issue>2</issue>
            <fpage>534</fpage>
            <page-range>534-9</page-range>
            <pub-id pub-id-type="pmid">2298864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kargili</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Turgut</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Karakurt</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kasapoglu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kanbay</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Akcay</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A forgotten but important risk factor for severe hyponatremia: myxedema coma.</article-title>
            <source>Clinics (Sao Paulo)</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>65</volume>
            <issue>4</issue>
            <fpage>447</fpage>
            <page-range>447-8</page-range>
            <pub-id pub-id-type="pmid">20454504</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koide</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Oda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nabeshima</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Maruyama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamashita</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Hyponatremia without inappropriate secretion of vasopressin in a case of myxedema coma.</article-title>
            <source>Endocrinol Jpn</source>
            <year>1982</year>
            <month>Jun</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>363</fpage>
            <page-range>363-8</page-range>
            <pub-id pub-id-type="pmid">7173113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skowsky</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Kikuchi</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>The role of vasopressin in the impaired water excretion of myxedema.</article-title>
            <source>Am J Med</source>
            <year>1978</year>
            <month>Apr</month>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>613</fpage>
            <page-range>613-21</page-range>
            <pub-id pub-id-type="pmid">645727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Derubertis</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Michelis</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Bloom</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Mintz</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Field</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>BB</given-names>
              </name>
            </person-group>
            <article-title>Impaired water excretion in myxedema.</article-title>
            <source>Am J Med</source>
            <year>1971</year>
            <month>Jul</month>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-53</page-range>
            <pub-id pub-id-type="pmid">5570319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nitu-Whalley</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Acquired von Willebrand syndrome--report of 10 cases and review of the literature.</article-title>
            <source>Haemophilia</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>5</volume>
            <issue>5</issue>
            <fpage>318</fpage>
            <page-range>318-26</page-range>
            <pub-id pub-id-type="pmid">10583513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olukman</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Sahin</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kavakli</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kavakli</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Investigation of acquired von Willebrand Syndrome in children with hypothyroidism: reversal after treatment with thyroxine.</article-title>
            <source>J Pediatr Endocrinol Metab</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>23</volume>
            <issue>9</issue>
            <fpage>967</fpage>
            <page-range>967-74</page-range>
            <pub-id pub-id-type="pmid">21175099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Myxedema coma: a sleeping giant in clinical practice.</article-title>
            <source>Am J Med</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>126</volume>
            <issue>12</issue>
            <fpage>e3</fpage>
            <page-range>e3-4</page-range>
            <pub-id pub-id-type="pmid">24262739</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liamis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Filippatos</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Liontos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Elisaf</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>MANAGEMENT OF ENDOCRINE DISEASE: Hypothyroidism-associated hyponatremia: mechanisms, implications and treatment.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>176</volume>
            <issue>1</issue>
            <fpage>R15</fpage>
            <page-range>R15-R20</page-range>
            <pub-id pub-id-type="pmid">27484454</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sheu</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Myxedema coma: a well-known but unfamiliar medical emergency.</article-title>
            <source>Thyroid</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>371</fpage>
            <page-range>371-2</page-range>
            <pub-id pub-id-type="pmid">17465870</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wartofsky</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Burman</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome".</article-title>
            <source>Endocr Rev</source>
            <year>1982</year>
            <season>Spring</season>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>164</fpage>
            <page-range>164-217</page-range>
            <pub-id pub-id-type="pmid">6806085</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horton</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Coburn</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>England</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Himsworth</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>The haematology of hypothyroidism.</article-title>
            <source>Q J Med</source>
            <year>1976</year>
            <month>Jan</month>
            <volume>45</volume>
            <issue>177</issue>
            <fpage>101</fpage>
            <page-range>101-23</page-range>
            <pub-id pub-id-type="pmid">1257398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doran</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>The origin of the elevated activities of creatine kinase and other enzymes in the sera of patients with myxoedema.</article-title>
            <source>Clin Chim Acta</source>
            <year>1975</year>
            <month>Jul</month>
            <day>23</day>
            <volume>62</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-11</page-range>
            <pub-id pub-id-type="pmid">1149287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olsen</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Myxedema coma in the elderly.</article-title>
            <source>J Am Board Fam Pract</source>
            <year>1995</year>
            <season>Sep-Oct</season>
            <volume>8</volume>
            <issue>5</issue>
            <fpage>376</fpage>
            <page-range>376-83</page-range>
            <pub-id pub-id-type="pmid">7484225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mazzaferri</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Surks</surname>
                <given-names>MI</given-names>
              </name>
            </person-group>
            <article-title>Recognizing the faces of hypothyroidism.</article-title>
            <source>Hosp Pract (1995)</source>
            <year>1999</year>
            <month>Mar</month>
            <day>15</day>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>93</fpage>
            <page-range>93-6, 101-5, 109; discussion 109-10</page-range>
            <pub-id pub-id-type="pmid">10089928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Popoveniuc</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sud</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blackman</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Burman</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Mete</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Desale</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wartofsky</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A diagnostic scoring system for myxedema coma.</article-title>
            <source>Endocr Pract</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>20</volume>
            <issue>8</issue>
            <fpage>808</fpage>
            <page-range>808-17</page-range>
            <pub-id pub-id-type="pmid">24518183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hylander</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rosenqvist</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Treatment of myxoedema coma--factors associated with fatal outcome.</article-title>
            <source>Acta Endocrinol (Copenh)</source>
            <year>1985</year>
            <month>Jan</month>
            <volume>108</volume>
            <issue>1</issue>
            <fpage>65</fpage>
            <page-range>65-71</page-range>
            <pub-id pub-id-type="pmid">3969812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beynon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Akhtar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kearney</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Predictors of outcome in myxoedema coma.</article-title>
            <source>Crit Care</source>
            <year>2008</year>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>111</fpage>
            <pub-id pub-id-type="pmid">18254932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dutta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bhansali</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Masoodi</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Bhadada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rajput</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Predictors of outcome in myxoedema coma: a study from a tertiary care centre.</article-title>
            <source>Crit Care</source>
            <year>2008</year>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>R1</fpage>
            <pub-id pub-id-type="pmid">18173846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwaku</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Burman</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Myxedema coma.</article-title>
            <source>J Intensive Care Med</source>
            <year>2007</year>
            <season>Jul-Aug</season>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>224</fpage>
            <page-range>224-31</page-range>
            <pub-id pub-id-type="pmid">17712058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sterns</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Nigwekar</surname>
                <given-names>SU</given-names>
              </name>
              <name>
                <surname>Hix</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>The treatment of hyponatremia.</article-title>
            <source>Semin Nephrol</source>
            <year>2009</year>
            <month>May</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>282</fpage>
            <page-range>282-99</page-range>
            <pub-id pub-id-type="pmid">19523575</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>HOLVEY</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>GOODNER</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>NICOLOFF</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>DOWLING</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>TREATMENT OF MYXEDEMA COMA WITH INTRAVENOUS THYROXINE.</article-title>
            <source>Arch Intern Med</source>
            <year>1964</year>
            <month>Jan</month>
            <volume>113</volume>
            <fpage>89</fpage>
            <page-range>89-96</page-range>
            <pub-id pub-id-type="pmid">14067598</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jonklaas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bianco</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Burman</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Cappola</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Celi</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Peeters</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Rosenthal</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Sawka</surname>
                <given-names>AM</given-names>
              </name>
              <collab>American Thyroid Association Task Force on Thyroid Hormone Replacement</collab>
            </person-group>
            <article-title>Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.</article-title>
            <source>Thyroid</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>12</issue>
            <fpage>1670</fpage>
            <page-range>1670-751</page-range>
            <pub-id pub-id-type="pmid">25266247</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>PAULL</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>PHILLIPS</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Primary myxedema with secondary adrenocortical failure.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1954</year>
            <month>May</month>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>554</fpage>
            <page-range>554-60</page-range>
            <pub-id pub-id-type="pmid">13152177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>PETERSON</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>WYNGAARDEN</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>GUERRA</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>BRODIE</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>BUNIM</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>The physiological disposition and metabolic fate of hydrocortisone in man.</article-title>
            <source>J Clin Invest</source>
            <year>1955</year>
            <month>Dec</month>
            <volume>34</volume>
            <issue>12</issue>
            <fpage>1779</fpage>
            <page-range>1779-94</page-range>
            <pub-id pub-id-type="pmid">13271563</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mooradian</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Scarpace</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>3,5,3'-L-triiodothyronine regulation of beta-adrenergic receptor density and adenylyl cyclase activity in synaptosomal membranes of aged rats.</article-title>
            <source>Neurosci Lett</source>
            <year>1993</year>
            <month>Oct</month>
            <day>14</day>
            <volume>161</volume>
            <issue>1</issue>
            <fpage>101</fpage>
            <page-range>101-4</page-range>
            <pub-id pub-id-type="pmid">8255534</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charoensri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sriphrapradang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nimitphong</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Split high-dose oral levothyroxine treatment as a successful therapy option in myxedema coma.</article-title>
            <source>Clin Case Rep</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>5</volume>
            <issue>10</issue>
            <fpage>1706</fpage>
            <page-range>1706-1711</page-range>
            <pub-id pub-id-type="pmid">29026577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ueda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kiyota</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tsuchida</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Okazaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ozaki</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment of myxedema coma with a combination of levothyroxine and liothyronine.</article-title>
            <source>Endocr J</source>
            <year>2019</year>
            <month>May</month>
            <day>28</day>
            <volume>66</volume>
            <issue>5</issue>
            <fpage>469</fpage>
            <page-range>469-474</page-range>
            <pub-id pub-id-type="pmid">30853666</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ladenson</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Goldenheim</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Ridgway</surname>
                <given-names>EC</given-names>
              </name>
            </person-group>
            <article-title>Early peripheral responses to intravenous L-thyroxine in primary hypothyroidism.</article-title>
            <source>Am J Med</source>
            <year>1982</year>
            <month>Oct</month>
            <volume>73</volume>
            <issue>4</issue>
            <fpage>467</fpage>
            <page-range>467-74</page-range>
            <pub-id pub-id-type="pmid">7124775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kollmar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schellinger</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Bardutzky</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Meisel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schwaninger</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Myxedema coma as a rare differential diagnosis of severe consciousness disturbance].</article-title>
            <source>Nervenarzt</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>73</volume>
            <issue>12</issue>
            <fpage>1183</fpage>
            <page-range>1183-5</page-range>
            <pub-id pub-id-type="pmid">12486569</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25498.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arlot</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Debussche</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Lalau</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Mesmacque</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tolani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Quichaud</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fournier</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Myxoedema coma: response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment.</article-title>
            <source>Intensive Care Med</source>
            <year>1991</year>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>16</fpage>
            <page-range>16-8</page-range>
            <pub-id pub-id-type="pmid">2037720</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
